{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:14:16Z","timestamp":1790266456241,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T00:00:00Z","timestamp":1569283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-11-LABX-0028-01"],"award-info":[{"award-number":["ANR-11-LABX-0028-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-15-CE16-0015"],"award-info":[{"award-number":["ANR-15-CE16-0015"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["DEQ20140329490"],"award-info":[{"award-number":["DEQ20140329490"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.omtn.2019.09.018","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T19:39:59Z","timestamp":1569526799000},"page":"546-553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Reduction of Fmr1 mRNA Levels Rescues Pathological Features in Cortical Neurons in a Model of FXTAS"],"prefix":"10.1016","volume":"18","author":[{"given":"Malgorzata","family":"Drozd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Delhaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Maurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Castagnola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Grossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Brau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marielle","family":"Jarjat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Willemsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Capovilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate K.","family":"Hukema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo","family":"Lalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Bardoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2019.09.018_bib1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/1096-8628(200022)97:2<153::AID-AJMG7>3.0.CO;2-M","article-title":"FMR1 gene and fragile X syndrome","volume":"97","author":"Bardoni","year":"2000","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.omtn.2019.09.018_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1086\/302720","article-title":"Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome","volume":"66","author":"Tassone","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2019.09.018_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-013-1138-1","article-title":"Fragile X-associated tremor\/ataxia syndrome (FXTAS): pathology and mechanisms","volume":"126","author":"Hagerman","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.omtn.2019.09.018_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1866-1955-6-25","article-title":"Mouse models of the fragile X premutation and fragile X-associated tremor\/ataxia syndrome","volume":"6","author":"Berman","year":"2014","journal-title":"J.\u00a0Neurodev. Disord."},{"key":"10.1016\/j.omtn.2019.09.018_bib5","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.molcel.2016.02.034","article-title":"CGG Repeat-Associated Non-AUG Translation utilizes a cap-dependent scanning mechanism of initiation to produce toxic proteins","volume":"62","author":"Kearse","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2019.09.018_bib6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.neuron.2016.12.016","article-title":"Translation of Expanded CGG Repeats into FMRpolyG Is Pathogenic and May Contribute to Fragile X Tremor Ataxia Syndrome","volume":"93","author":"Sellier","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.omtn.2019.09.018_bib7","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1080\/13854046.2016.1186661","article-title":"Fragile X-associated tremor\/ataxia syndrome: another phenotype of the fragile X gene","volume":"30","author":"Hessl","year":"2016","journal-title":"Clin. Neuropsychol."},{"key":"10.1016\/j.omtn.2019.09.018_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/978-3-642-21649-7_14","article-title":"Mouse models of the fragile x premutation and the fragile X associated tremor\/ataxia syndrome","volume":"54","author":"Hunsaker","year":"2012","journal-title":"Results Probl. Cell Differ."},{"key":"10.1016\/j.omtn.2019.09.018_bib9","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1037\/a0017616","article-title":"Progressive spatial processing deficits in a mouse model of the fragile X premutation","volume":"123","author":"Hunsaker","year":"2009","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.omtn.2019.09.018_bib10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/hmg\/ddp479","article-title":"Murine hippocampal neurons expressing Fmr1 gene premutations show early developmental deficits and late degeneration","volume":"19","author":"Chen","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2019.09.018_bib11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/hmg\/ddq432","article-title":"Premutation CGG-repeat expansion of the Fmr1 gene impairs mouse neocortical development","volume":"20","author":"Cunningham","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2019.09.018_bib12","first-page":"463","article-title":"New insights into the regulatory function of CYFIP1 in the context of WAVE- and FMRP-containing complexes","volume":"10","author":"Abekhoukh","year":"2017","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.omtn.2019.09.018_bib13","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1093\/hmg\/ddt044","article-title":"The 3\u2032 UTR of FMR1 mRNA is a target of miR-101, miR-129-5p and miR-221: implications for the molecular pathology of FXTAS at the synapse","volume":"22","author":"Zongaro","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2019.09.018_bib14","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1523\/JNEUROSCI.21-14-05139.2001","article-title":"Abnormal development of dendritic spines in FMR1 knock-out mice","volume":"21","author":"Nimchinsky","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.omtn.2019.09.018_bib15","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1093\/cercor\/bhy192","article-title":"Involvement of Phosphodiesterase 2A Activity in the Pathophysiology of Fragile X Syndrome","volume":"29","author":"Maurin","year":"2018","journal-title":"Cereb. Cortex"},{"issue":"Suppl 1","key":"10.1016\/j.omtn.2019.09.018_bib16","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1528-1167.2012.03486.x","article-title":"Abnormal dendrite and spine morphology in primary visual cortex in the CGG knock-in mouse model of the fragile X premutation","volume":"53","author":"Berman","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.omtn.2019.09.018_bib17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/aob\/mcw001","article-title":"Proteome analysis of digestive fluids in Nepenthes pitchers","volume":"117","author":"Rottloff","year":"2016","journal-title":"Ann. Bot."},{"key":"10.1016\/j.omtn.2019.09.018_bib18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.yapd.2009.08.008","article-title":"Fragile X: a family of disorders","volume":"56","author":"Chonchaiya","year":"2009","journal-title":"Adv. Pediatr."},{"key":"10.1016\/j.omtn.2019.09.018_bib19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.brainres.2012.06.052","article-title":"Distribution and frequency of intranuclear inclusions in female CGG KI mice modeling the fragile X premutation","volume":"1472","author":"Schluter","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.omtn.2019.09.018_bib20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.gene.2007.02.026","article-title":"Regional FMRP deficits and large repeat expansions into the full mutation range in a new Fragile X premutation mouse model","volume":"395","author":"Entezam","year":"2007","journal-title":"Gene"},{"key":"10.1016\/j.omtn.2019.09.018_bib21","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s13311-017-0555-6","article-title":"Open-Label Allopregnanolone Treatment of Men with Fragile X-Associated Tremor\/Ataxia Syndrome","volume":"14","author":"Wang","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.omtn.2019.09.018_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s40478-019-0796-1","article-title":"Composition of the Intranuclear Inclusions of Fragile X-associated Tremor\/Ataxia Syndrome","volume":"7","author":"Ma","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.omtn.2019.09.018_bib23","doi-asserted-by":"crossref","first-page":"11411","DOI":"10.1523\/JNEUROSCI.2360-16.2016","article-title":"Synaptic Actin Dysregulation, a Convergent Mechanism of Mental Disorders?","volume":"36","author":"Yan","year":"2016","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.omtn.2019.09.018_bib24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/21541248.2016.1277001","article-title":"Critical importance of RAB proteins for synaptic function","volume":"9","author":"Mignogna","year":"2018","journal-title":"Small GTPases"},{"key":"10.1016\/j.omtn.2019.09.018_bib25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/mds.27270","article-title":"The emerging role of Rab GTPases in the pathogenesis of Parkinson\u2019s disease","volume":"33","author":"Gao","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.omtn.2019.09.018_bib26","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.ajhg.2012.04.020","article-title":"The contribution of CLIP2 haploinsufficiency to the clinical manifestations of the Williams-Beuren syndrome","volume":"90","author":"Vandeweyer","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2019.09.018_bib27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0166-2236(00)02118-4","article-title":"Rho proteins, mental retardation and the cellular basis of cognition","volume":"25","author":"Ramakers","year":"2002","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.omtn.2019.09.018_bib28","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.4161\/15384101.2014.943112","article-title":"Induced expression of expanded CGG RNA causes mitochondrial dysfunction in\u00a0vivo","volume":"13","author":"Hukema","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.omtn.2019.09.018_bib29","doi-asserted-by":"crossref","first-page":"6896","DOI":"10.1007\/s12035-016-0194-7","article-title":"Impaired Mitochondrial Function and Dynamics in the Pathogenesis of FXTAS","volume":"54","author":"Alvarez-Mora","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.omtn.2019.09.018_bib30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.euroneuro.2018.01.002","article-title":"Anterior cingulate cortex glutamate and its association with striatal functioning during cognitive control","volume":"28","author":"Naaijen","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.omtn.2019.09.018_bib31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.baga.2013.09.001","article-title":"Glutamate in Parkinson\u2019s disease: Role of antiglutamatergic drugs","volume":"3","author":"Carrillo-Mora","year":"2013","journal-title":"Basal Ganglia"},{"key":"10.1016\/j.omtn.2019.09.018_bib32","doi-asserted-by":"crossref","first-page":"806","DOI":"10.3389\/fneur.2018.00806","article-title":"Beyond Dopamine: GABA, Glutamate, and the Axial Symptoms of Parkinson Disease","volume":"9","author":"O\u2019Gorman Tuura","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.omtn.2019.09.018_bib33","article-title":"Targeting the Small GTPase Superfamily through their Regulatory Proteins","author":"Gray","year":"2019","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.omtn.2019.09.018_bib34","doi-asserted-by":"crossref","first-page":"e0165499","DOI":"10.1371\/journal.pone.0165499","article-title":"Reactivation of FMR1 by CRISPR\/Cas9-Mediated Deletion of the Expanded CGG-Repeat of the Fragile X Chromosome","volume":"11","author":"Xie","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtn.2019.09.018_bib35","doi-asserted-by":"crossref","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.omtn.2019.09.018_bib36","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1093\/hmg\/10.16.1693","article-title":"Instability of a (CGG)98 repeat in the Fmr1 promoter","volume":"10","author":"Bontekoe","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2019.09.018_bib37","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/stem.2505","article-title":"Depletion of the Fragile X mental retardation protein in embryonic stem cells alters the kinetics of neurogenesis","volume":"35","author":"Khalfallah","year":"2017","journal-title":"Stem Cells"},{"key":"10.1016\/j.omtn.2019.09.018_bib38","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1093\/nar\/gky267","article-title":"HITS-CLIP in various brain areas reveals new targets and new modalities of RNA binding by fragile X mental retardation protein","volume":"46","author":"Maurin","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2019.09.018_bib39","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1093\/hmg\/ddg181","article-title":"82-FIP, a novel FMRP (fragile X mental retardation protein) interacting protein, shows a cell cycle-dependent intracellular localization","volume":"12","author":"Bardoni","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2019.09.018_bib40","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1186\/gb-2007-8-9-r183","article-title":"The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists","volume":"8","author":"Huang","year":"2007","journal-title":"Genome Biol."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253119302653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253119302653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:38:53Z","timestamp":1784651933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253119302653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":40,"alternative-id":["S2162253119302653"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2019.09.018","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduction of Fmr1 mRNA Levels Rescues Pathological Features in Cortical Neurons in a Model of FXTAS","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2019.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors.","name":"copyright","label":"Copyright"}]}}